Ratings Smaregi, Inc.

Equities

4431

JP3400110007

Market Closed - Japan Exchange Other stock markets 07:00:00 02/05/2024 BST			5-day change	1st Jan Change
2,292 ^JPY	+0.92%		+3.52%	-15.39%

04-22	Smaregi to Buy Ligua's Patient Information Management Platform for 176 Million Yen	MT
04-16	Smaregi, Inc. agreed to acquire Rece ONE Plus business from Ligua Inc. from Ligua Inc. for approximately ¥180 million.	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
The group's high margin levels account for strong profits.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

With an expected P/E ratio at 52.25 and 39.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
The valuation of the company is particularly high given the cash flows generated by its activity.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Software

	1st Jan change	Capi.	ESG Refinitiv
SMAREGI, INC.	-15.39%	288M	-
ADOBE INC.	-18.51%	218B	B
WORKDAY INC.	-7.35%	67.86B	B-
ROPER TECHNOLOGIES, INC.	-5.13%	55.36B	B
AUTODESK, INC.	-11.62%	46.03B	A-
DATADOG, INC.	+2.38%	41.53B	C
ELECTRONIC ARTS INC.	-5.30%	34.64B	B
ANSYS, INC.	-11.95%	27.89B	B
APPLOVIN CORPORATION	+88.38%	24.73B	-
PTC INC.	+0.46%	21.01B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes